Por favor, use este identificador para citar o enlazar este ítem:
http://conacyt.repositorioinstitucional.mx/jspui/handle/1000/838| High-dose intravenous immunoglobulin as a therapeutic option for deteriorating patients with Coronavirus Disease 2019 | |
| Cao, W Liu, X Bai, T Fan, H Hong, K Song, H Han, Y Lin, L Ruan, L Li, T | |
| Acceso Abierto | |
| Atribución-NoComercial-SinDerivadas | |
| Abstract The outbreak of Coronavirus Disease 2019 (COVID-19) has spread rapidly in China. Till now, no definite effective treatment has been identified. We reported on three patients of severe COVID-19 who received high-dose intravenous immunoglobulin (IVIg) with satisfactory recovery. Based on these observations, randomized studies of high-dose IVIg should be considered in deteriorating patients infected with COVID-19. | |
| Open Forum Infectious Diseases | |
| 2020 | |
| Preimpreso | |
| https://coronavirus.1science.com/item/e80ab87c5b9e3010cc01545581f8025aa939b7b7 | |
| Inglés | |
| VIRUS RESPIRATORIOS | |
| Aparece en las colecciones: | Artículos científicos |
Cargar archivos:
| Fichero | Tamaño | Formato | |
|---|---|---|---|
| 102791.pdf | 431.98 kB | Adobe PDF | Visualizar/Abrir |